The essential role of resistin, as well as its association with gastric cancer, make it a factor of concern as well as a potential a biomarker for gastric cancer progression [18]; therefore, it is clinically relevant to study the mechanism by which resistin influences tumor cells. This evidence concerns the gene RETN and neoplasm.